Recent Investment Analysts’ Ratings Changes for LifeStance Health Group (LFST)

by · The Cerbat Gem

Several analysts have recently updated their ratings and price targets for LifeStance Health Group (NASDAQ: LFST):

  • 12/12/2025 – LifeStance Health Group had its price target raised by analysts at BTIG Research from $9.00 to $10.00. They now have a “buy” rating on the stock.
  • 12/9/2025 – LifeStance Health Group is now covered by analysts at Barclays PLC. They set an “overweight” rating and a $8.00 price target on the stock.
  • 12/8/2025 – LifeStance Health Group had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings.
  • 12/8/2025 – LifeStance Health Group was upgraded by analysts at Barclays PLC to a “strong-buy” rating.
  • 12/1/2025 – LifeStance Health Group had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings.
  • 11/25/2025 – LifeStance Health Group had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings.
  • 11/19/2025 – LifeStance Health Group had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings.
  • 11/13/2025 – LifeStance Health Group had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings.
  • 11/13/2025 – LifeStance Health Group is now covered by analysts at BMO Capital Markets. They set an “outperform” rating and a $8.00 price target on the stock.
  • 11/7/2025 – LifeStance Health Group had its price target raised by analysts at UBS Group AG from $9.00 to $10.00. They now have a “buy” rating on the stock.
  • 11/6/2025 – LifeStance Health Group had its price target raised by analysts at BTIG Research from $8.00 to $9.00. They now have a “buy” rating on the stock.
  • 11/5/2025 – LifeStance Health Group was downgraded by analysts at Zacks Research from a “strong-buy” rating to a “hold” rating.

Insider Transactions at LifeStance Health Group

In other LifeStance Health Group news, insider Lisa K. Miller sold 57,240 shares of the company’s stock in a transaction dated Friday, November 21st. The shares were sold at an average price of $6.43, for a total value of $368,053.20. Following the sale, the insider owned 261,292 shares of the company’s stock, valued at $1,680,107.56. This represents a 17.97% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 6.60% of the company’s stock.

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

Read More